Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Voythos logo — Transforming aortic disease with predictive intelligence.

Voythos

Transforming aortic disease with predictive intelligence.

Founded 2021 United States Houston, United States 2 employees Pre-Seed Total: $180.00K AI, Health Care +1

General Information

Company Name Voythos
Founded Year 2021
Location United States Houston, United States
Employees 2
Industries AI, Health Care, Clean Energy
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with Voythos. To contact Voythos, visit voythos.io.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Voythos compare?

A PDF of Voythos and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Voythos soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Voythos

Voythos, founded in 2021, is a pioneering AI informatics company focused on healthcare innovations, specifically targeting aortic disease. The company's slogan, "Transforming aortic disease with predictive intelligence," underscores their mission to develop cutting-edge multimodal machine learning models. These models aim to predict and prevent life-threatening complications, enabling earlier intervention by cardiovascular surgeons, thereby saving lives and limbs.

Headquartered in the United States, Voythos is situated at the intersection of AI, Health Care, and Clean Energy industries. In 2022, they secured a $180.00K Pre Seed Round investment from renowned investors such as Forum Ventures and Right Side Capital Management. This financial backing highlights investor confidence in Voythos’s innovative solutions and potential for substantial impacts in cardiology.

Business keywords: AI informatics, multimodal machine learning, predictive modeling, aortic disease, cardiovascular surgeons, clinical data, data fusion, bioinformatics, precision medicine, predictive intelligence, medical diagnostics, life-threatening complications, healthcare analytics

Services & Products

Developing predictive software for aortic disease risk assessment and treatment decision support.

Target Customers

Cardiovascular surgeons healthcare institutions patients with complex vascular diseases.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round $180.00K 2
Forum Ventures Right Side Capital Management
Forum Ventures, Right Side Capital Management
01 Jan 2022

Voythos Alternatives & Competitors

View All Alternatives
Voythos vs
Viz.ai
Viz.ai United States

AI-powered disease detection and care coordination platform

327 employees
AI, Health Care
Voythos vs
MarkaSCI
MarkaSCI Turkey

Yapay Zeka ile insan sağlığının geleceğini şekillendiriyoruz.

1 employees
AI, Digital Health
Voythos vs
Heartflow
Heartflow United States

Decisive Coronary Care.

IPO
823 employees
AI, Biotechnology
Also compare with: Voythos vs Prenosis Prenosis View all alternatives

FAQ About Voythos

Transforming aortic disease with predictive intelligence.
Voythos was founded in 2021.
Voythos is headquartered in Houston, United States.
Voythos operates in AI, Health Care and Clean Energy. Its work centres on AI informatics, multimodal machine learning, predictive modeling and aortic disease. Its customers include Cardiovascular surgeons, healthcare institutions and patients with complex vascular diseases..
Voythos has approximately 2 employees.
Voythos has completed 1 funding round, raising a total of $180.00K. The latest funding stage is Pre-Seed.
Voythos offers: Developing predictive software for aortic disease risk assessment and treatment decision support..
Top alternatives and competitors to Voythos include Viz.ai, MarkaSCI, Heartflow, Aignostics, Aktiia. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Voythos and Viz.ai are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Voythos, https://bouncewatch.com/company/voythos, updated 14 November 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes